Cancer Drug Treats MS
http://www.skynews.com.au/health/article.aspx?id=811785
A cancer drug may be a new option for treating multiple sclerosis. Two new studies show that the drug alemtuzumab reduces relapse rates, and disability.
Mass. Movers Vertex up on hepatitis deals
http://bostonglobe.com/business/markets/2012/11/01/vertex-pharmaceuticals-stock-advances/wpZEw0aH2wJh0v3AsGcaDJ/story.html
Vertex Pharmaceuticals Inc. said it has entered into deals with GlaxoSmithKline and Janssen Pharmaceuticals to work on potential treatments for hepatitis C. Cambridge-based Vertex already has a hepatitis C drug on the market called Incivek.
Carr commits $100m to tackle malaria
http://www.google.com/hostednews/afp/article/ALeqM5iBLqKjQ3XqxMqKqq5l7cNTbxdddA?docId=CNG.4268a9b81e1a2aebb34dfaef1b225f98.241
Australia has committed $100 million over the next four years to reduce death and illness from malaria in the Asia-Pacific region.
No comments:
Post a Comment